Andrew Martin Kay
CIK: 0002117361
Transaction Breakdown
Open Market Buys (P)0
High conviction signal
Open Market Sales (S)0
Position reduction
Option Exercises (M)0
Derivative conversions
Awards (A)0
Compensation grants
Other (G, F, J, C, D, …)0
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
NCNA
NuCana plc
Director
Discretionary Trading P&L
Holdings
Transaction History (0 total)
1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024.
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| 1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024. | ||||||
0-0 of 0 transactions
About Kay Andrew Martin
Kay Andrew Martin (SEC CIK 0002117361) files insider reports with the SEC as Director of NuCana plc (NCNA).
Signal8 holds 1 ownership filing by Kay Andrew Martin, a Form 3, filed on Mar 18, 2026. A Form 3 is an initial statement of ownership: it reports holdings, not trades, so no Form 4 or Form 5 transactions are on record since Sep 2024.
The business address on Kay Andrew Martin's filings is in EDINBURGH.
Other insiders filing for NuCana plc (NCNA)
- Levy Elliott M., Director
- Bloss Jeffrey D., Chief Medical Officer
- Bruce Theresa Margaret Ms, Chief Operating Officer
- Harrison David James, Head of Translational Medicine
- Mellish Martin C.B., Director
- Webster Ian Alexander